2021 Volume 36 Issue 1 Pages 35-39
Erectile dysfunction (ED) is defined as the inability to achieve and maintain a penile erection adequate for satisfactory sexual intercourse. There are many causes of ED. Although, it is often multifactorial, one of the most common causes of organic ED is arterial steno-occlusive disease. Arteriogenic ED is mainly attributed to steno-occlusive disease of the internal iliac, internal pudendal, common penile, dorsal penile artery, which compromises the arterial inflow to the penile corpora cavernosa. Oral phosphodiesterase - 5 inhibitor is the first-line treatment for organic ED. When oral ED therapy fails, subsequent therapies are progressively invasive and include intracavernosal injections, vacuum devices, surgical revascularization, and penile prostheses. Recently, angioplasty aims to offer a less invasive alternative to surgical revascularization. Angioplasty is performed by standard balloon dilatation procedures. In the previous reports, the procedural success rate was 90-100%. However, the restenosis rate was reported to be 30-40%. Angioplasty for refractory arteriogenic ED can be one of the treatment options.
